Subsequent Kaplan-Meier analyses revealed that patients with MYBL2 High lung adenocarcinomas had significantly worse OS rates, compared to patients with MYBL2 Low lung adenocarcinomas (ΔMMS = 49.6 months, log-rank p = 2.2e–3) (Figure 2A). This evidence concerns the gene MYBL2 and lung adenocarcinoma.